drugset / Trial / NCT02633761
Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary aim of this trial is to compare the efficacy of mifepristone-misoprostol versus misoprostol alone for treatment of intrauterine fetal demise between 14 and 28 weeks LMP.
Timeline
- Start
- 2015-04-01
- Primary completion
- 2018-12-30
- Completion
- 2018-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mifepristone | Small molecule | 200 mg | — |
| Comparator | Misoprostol | Other / unclassified | 200 ug | Other |